RecruitingNCT07145411

HPC Offered for PRESERVE Expansion


Sponsor

Ossium Health, Inc.

Enrollment

10 participants

Start Date

Jun 27, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product


Eligibility

Min Age: 12 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is offering bone marrow (hematopoietic progenitor cell, or HPC) transplantation from a specialized bone marrow donor bank called Ossium through the HOPE Program (PRESERVE Expansion). It is designed for patients who need an allogeneic (donor) bone marrow transplant to treat their disease. **You may be eligible if...** - You are between 12 and 80 years old - Your treating doctor has determined that you need a donor bone marrow transplant - Your doctor believes the potential benefit of the transplant outweighs the potential risks for you specifically **You may NOT be eligible if...** - Your doctor has not determined you are a candidate for allogeneic bone marrow transplantation - The risks of transplant are considered too high for your specific situation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)

The HOPE Program does not include any investigational drugs. The medicines and procedures in this program are standard of care for a transplant. Bone marrow cells from a deceased organ and tissue donor for use in your transplant is the only product offered to you by Ossium Health.


Locations(4)

University of Alabama, Birmingham

Birmingham, Alabama, United States

Henry Ford Health

Detroit, Michigan, United States

The Ohio State University Medical Center

Columbus, Ohio, United States

Tristar Centennial Medical Center

Nashville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07145411